Faculty Profile for Dr. Liqin Du

profile photo for Dr. Liqin Du
Dr. Liqin Du
Assistant Professor — Chemistry and Biochemistry
Program Faculty — Chemistry and Biochemistry
CHEM 212
phone: (512) 245-1038

Selected Scholarly/Creative Work

  • Rastogi, S. K., Zhao, Z., Barrett, S. L., Shelton, S. D., Zafferani, M., Anderson, H. E., … Brittain, W. J. (2018). Photoresponsive azo-combretastatin A-4 analogues. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 143, 1–7. https://doi.org/10.1016/j.ejmech.2017.11.012
  • Zhao, Z., Partridge, V., Sousares, M., Shelton, S., Holland, C., Pertsemlidis, A., & Du, L. (2018). Differentiation-inducing microRNA-2110 functions as a tumor suppressor in neuroblastoma by directly targeting TSKU. PLos One, 13(12), e0208777.
  • Du, L., Zhao, Z., Milind, S., Shelton, S. S., Tzu-Hung, H., Ma, X., … Pertsemlidis, A. (2018). LMO1 functions an oncogene through regulating TTK expression and correlates with neuroendocrine differentiation of lung caner. Oncotarget, 9, 29601–29618.
  • Shelton, S. D., Zhao, Z., & Du, L. (2018). RXRA is a direct target gene of miR-506-3p that regulates oncogene MYCN expression and cell differentiation in neuroblastoma. FASEB Journal, 32(No.1 Suppl). Retrieved from www.fasebj.org/content/32/1_Supplement/804.16
  • Medrano, G., Zhao, Z., & Du, L. (2018). The Role of the Vacuolar (H+)-ATPase in Neuroblastoma Cell Differentiation induced by microRNA 506-3p. FASEB Journal, 32(No.1 Suppl). Retrieved from www.fasebj.org/content/32/1_Supplement/804.3

Selected Awards

  • Award / Honor Recipient: Hua Rui Prize, Sino-Swed Pharmaceutical Corp. Ltd. 1997
  • Award / Honor Recipient: Scholarship for Outstanding Graduate, Shanghai Second Medical University, China. 1996
  • Award / Honor Recipient: Scholarship for Outstanding Graduate, Shanghai Second Medical University, China. 1995
  • Award / Honor Recipient: First Prize of People’s Scholarship, Shanghai Medical University, China. 1991
  • Award / Honor Recipient: First Prize of People’s Scholarship, Shanghai Medical University, China. 1990

Selected Grants

  • Du, Liqin (Principal), Kornienko, Alexander (Other), Houhgton, Peter (Other). Discovery of new differentiation agents for neuroblastoma therapy, National Institute of Health, NCI, Federal, $461574. (Funded: August 1, 2017 - July 31, 2020). Grant.
  • Du, Liqin (Principal). Determining the therapeutic potential of rooperol in neuroblastoma, REP Program, Texas State University, Texas State University, $8000. (Funded: January 1, 2017 - May 31, 2018). Grant.
  • Kerwin, S (Principal), Du, Liqin (Co-Principal). Hypoxis-derived treatment for advanced lung cancer, William and Ella Owens Medical Research Foundation, Private / Foundation / Corporate, $153109. (Funded: January 1, 2016 - December 31, 2017). Grant.
  • Du, Liqin (Principal). Identifying a novel oncogenic mechanism and diagnostic marker for neuroendocrine lung cancer, Peter Bradley Carlson Trust, $30000. (Funded: January 1, 2015 - December 31, 2015). Grant.
  • Pertsemlidis, A (Principal), Du, Liqin (Co-Principal). Elucidating how chromosome 21 protects against neuroblastoma occurrence, Institute for Integration of Medicine and Science, Institutional (Higher Ed), $50000. (Funded: October 4, 2014 - September 30, 2015). Grant.

Selected Service Activities

Other
Biochemistry Graduate Curriculum committee
2016-Present
Editorial Review Board Member
Med One
September 2016-Present
Other
Biochemistry Curriculum committee
2015-Present
Editorial Review Board Member
Advances in Modern Oncology Research
2015-Present
Editorial Review Board Member
Editorial Board: RNA and Disease
2014-Present